£1.8m funding for probiotics research | University of Oxford
Probiotic products
Probiotic products

Image credit: Tikta Alik/ Shutterstock

£1.8m funding for probiotics research

Can probiotics prevent infections and reduce the need for antibiotics in care home residents?

Primary care researchers at the Universities of Oxford and Cardiff are beginning a £1.8m study to test whether a probiotic supplement can reduce the number of infections in care home residents, in a bid to cut antibiotic use in this high-risk group.

Probiotics are 'good bacteria' that can provide health benefits when taken as a supplement.

The family doctor’s toolkit of useful and effective antibiotics to treat common infections is coming under threat from increasing drug resistance in our population.

Dr Christopher Butler, GP and Professor of Primary Care at the Nuffield Department of Primary Care Health Sciences

Infections are the most common reason for care home residents to be hospitalised, and previous research shows care home residents are the biggest user group for antibiotics, which puts them at significant risk of developing antibiotic drug resistance. This resistance can spread to hospitals and the community – reducing the effectiveness of these important drugs to fight common infections.

The researchers will recruit 330 care home residents in Cardiff and Oxford and provide them with daily supplements of the widely available probiotics Lactobacillus rhamnosus,and Bifidobacterium animalis subspecies lactis, versus a placebo, over a period of 12 months. They will assess the total number of days on antibiotics for common infectious diseases, including flu-like illness, urinary tract infection, and skin and gastro-intestinal infections, in addition to their response to the influenza vaccine.

This project is funded by the Efficacy and Mechanism Evaluation (EME) Programme, a Medical Research Council and National Institute for Health Research partnership.

Christopher Butler, a GP for the Cwm Taf University Health Board and Professor of Primary Care at the University of Oxford’s Nuffield Department of Primary Care Health Sciences, who will lead the research, said:

'The family doctor’s toolkit of useful and effective antibiotics to treat common infections is coming under threat from increasing drug resistance in our population. Care home residents are prescribed far more antibiotics than the general population since they are more vulnerable to infections due to their weakened immunity, close proximity living and multi-morbidity. They are often hospitalised when the drugs stop working.

'Other than vaccination and good hygiene, there are few proven ways to prevent infections in older care home residents - so they represent an important target in efforts to combat antibiotic resistance. Our study should answer the question whether or not daily probiotics prevent infections. If successful, this cheap, safe probiotic could improve quality of life and contain antibiotic resistance in this growing vulnerable population, helping to preserve the effectiveness of our available antibiotic drugs into the future.'

Lactobacillus rhamnosus and Bifidobacterium animalis subspecies Lactis are live bacteria, and were chosen for this research because together they enhance immunity and may reduce the duration of common infectious diseases. However, there has been little research to date to support probiotic use in care home residents, and this study will fill that important gap.